应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LITS Lite Strategy Inc.
已收盘 08-27 16:00:00 EDT
1.00
+0.01
+0.69%
盘后
1.00
+0.00
0.00%
19:30 EDT
最高
1.05
最低
1.00
成交量
19.01万
今开
1.04
昨收
0.9931
日振幅
5.03%
总市值
3,403万
流通市值
3,182万
总股本
3,403万
成交额
19.60万
换手率
0.60%
流通股本
3,182万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Lite Strategy Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。
发行价格:
--
{"stockData":{"symbol":"LITS","market":"US","secType":"STK","nameCN":"Lite Strategy Inc.","latestPrice":1,"timestamp":1787860800000,"preClose":0.9931,"halted":0,"volume":190133,"hourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"19:30 EDT","volume":18,"amount":18.699,"timestamp":1787873404047,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.006947940791461099,"floatShares":31820400,"shares":34025200,"eps":-2.08,"marketStatus":"已收盘","change":0.0069,"latestTime":"08-27 16:00:00 EDT","open":1.04,"high":1.05,"low":1,"amount":196017.33115050002,"amplitude":0.050347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.08,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787904000000},"marketStatusCode":5,"adr":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":0.9931,"preHourTrading":{"tag":"盘前","latestPrice":1.0201,"preClose":0.9931,"latestTime":"09:09 EDT","volume":798,"amount":823.2290093999999,"timestamp":1787836169507,"change":0.027,"changeRate":0.027188,"amplitude":0.050247},"postHourTrading":{"tag":"盘后","latestPrice":1,"preClose":1,"latestTime":"19:30 EDT","volume":18,"amount":18.699,"timestamp":1787873404047,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.712102,"impliedVol":0.9697,"impliedVolPercentile":0.3651},"requestUrl":"/m/hq/s/LITS","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://litestrategy.com","stockEarnings":[{"period":"1week","weight":0.0565},{"period":"1month","weight":0.017},{"period":"3month","weight":-0.0264},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.8119},{"period":"ytd","weight":-0.2477}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1168},{"period":"1year","weight":0.1874},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lite Strategy, Inc.成立于2000年12月,是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。他们的候选药物管线包括voruciclib,一种口服细胞周期蛋白依赖性激酶9(CDK9)抑制剂和zandelisib,一种口服、每日一次、选择性PI3K δ抑制剂,这是一种临床前候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.05532},{"month":2,"riseRate":0.391304,"avgChangeRate":-0.008473},{"month":3,"riseRate":0.434783,"avgChangeRate":-0.069997},{"month":4,"riseRate":0.521739,"avgChangeRate":0.018779},{"month":5,"riseRate":0.434783,"avgChangeRate":0.032255},{"month":6,"riseRate":0.347826,"avgChangeRate":-0.083106},{"month":7,"riseRate":0.391304,"avgChangeRate":0.075503},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.009011},{"month":9,"riseRate":0.52381,"avgChangeRate":0.049595},{"month":10,"riseRate":0.380952,"avgChangeRate":-0.06395},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.039907},{"month":12,"riseRate":0.227273,"avgChangeRate":0.003146}],"exchange":"NASDAQ","name":"Lite Strategy Inc.","nameEN":"Lite Strategy Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lite Strategy Inc.,LITS,Lite Strategy Inc.股票,Lite Strategy Inc.股票老虎,Lite Strategy Inc.股票老虎国际,Lite Strategy Inc.行情,Lite Strategy Inc.股票行情,Lite Strategy Inc.股价,Lite Strategy Inc.股市,Lite Strategy Inc.股票价格,Lite Strategy Inc.股票交易,Lite Strategy Inc.股票购买,Lite Strategy Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lite Strategy Inc.(LITS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lite Strategy Inc.(LITS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}